← Leaderboards
Ray W Johnson
Indiana Univ-Purdue Univ At Indianapolis
$237,170
Attributed
$237,170
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $58.8K · FY2005–08$100K$75K$50K$25K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$237,170 · 8
By mechanism
M01$237,170 · 8
Top collaborators
No co-investigators on record.
Most similar at Indiana Univ-Purdue Univ At Indianapolis
Same institution · by research overlap
- Mitchell J Goldman$3,011,275
- Dennis Chua Ang$7,200,947
- Michael J Robertson$1,253,918
- Kurt Kroenke$8,377,491
- Kenneth P Nephew$7,005,060
Others in their field
Top investigators on “Peginterferon Alfa-2a”
- Lewis Silverman · Mount Sinai School Of Medicine Of Nyu$4,082,796
- Mandana Khalili · University Of California San Francisco$2,830,724
- Norah A. Terrault · University Of Southern California$2,830,724
- Anna Slavin$1,875,276
- Harry Janssen · University Health Network$1,826,726
- Luis J. Montaner · Wistar Institute$1,666,247
Research focus
Peginterferon Alfa-2aResearch PersonnelLabelOutcome Assessment (Health Care)RateResearch DesignInfectionInstitutionLiver FibrosisOphthalmic Examination And EvaluationProceduresElectrocardiogramEnrollmentFundingGrantBiopsy Of LiverHepatitisHepatitis C VirusHepatitis VirusesComputer Retrieval Of Information On Scientific Projects DatabaseBloodMaintenanceAntiviral AgentsResources
Grant awards (9)
SUPPRESSIVE LONG-TERM ANTIVIRAL MANAGEMENT OF HEPATITIS C VIRUS (HCV) AND HIV$6,133
M01 · FY2008 · RR · contact PI
SUPPRESSIVE LONG-TERM ANTIVIRAL MANAGEMENT OF HEPATITIS C VIRUS (HCV) AND HIV$25,726
M01 · FY2007 · RR · contact PI
SUPPRESSIVE LONG-TERM ANTIVIRAL MANAGEMENT OF HEPATITIS C VIRUS (HCV) AND HIV$27,778
M01 · FY2006 · RR · contact PI
INTERMITTENT WITHDRAWAL OF ANTIRETROVIRAL THERAPY-IMMUNIZATION WITH ALVAC-HIV$2,193
M01 · FY2006 · RR · contact PI
A SEQUENTIAL REGIMEN WITH PEGYLATED-INTERFERON -2A PLUS TENOFOVIR FOR CHRONIC$730
M01 · FY2006 · RR · contact PI
INTERMITTENT WITHDRAWAL OF ANTIRETROVIRAL THERAPY-IMMUNIZATION WITH ALVAC-HIV$44,487
M01 · FY2005 · RR
SUPPRESSIVE LONG-TERM ANTIVIRAL MANAGEMENT OF HEPATITIS C VIRUS (HCV) AND HIV$7,943
M01 · FY2005 · RR
A SEQUENTIAL REGIMEN WITH PEGYLATED-INTERFERON -2A PLUS TENOFOVIR FOR CHRONIC$6,356
M01 · FY2005 · RR
Intermittent Withdrawal of Antiretroviral Therapy-Immunization with ALVAC-HIV$115,824
M01 · FY2004 · RR